Both subjects, asymptomatic for Gaucher disease, were studied in order to confirm heterozygous compound mutation in the proband and to provide genetic counseling, since heterozygous mutations in the GBA1 gene are considered the main risk factor for the development of Parkinson’s disease. This evidence concerns the gene GBA1 and Parkinson disease.